secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2022-07-14T23:59:59+00:00
Accession:  0001493152-22-019301
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders approve 3M share increase to Omnibus Incentive Plan; director Islam retires
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2019 Omnibus Incentive Plan, raising share authorization from 3M to 6M shares.
- Dr. Khalid Islam retired from the Board effective as of the July 11, 2022 Annual Meeting.
- All five director nominees were elected; say-on-pay and auditor ratification passed.
- BD & Company, Inc. ratified as independent auditor for 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/0001493152-22-019301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer